Literature DB >> 19653251

Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation-independent mechanism which requires binding of Tat to viral particles.

Filomena Nappi1, Chiara Chiozzini, Valentina Bordignon, Alessandra Borsetti, Stefania Bellino, Marco Cippitelli, Giovanni Barillari, Antonella Caputo, Mudit Tyagi, Mauro Giacca, Barbara Ensoli.   

Abstract

BACKGROUND: Retroviral transduction of cells is improved upon virus adsorption onto immobilized fibronectin (FN) fragments. Because HIV-1 Tat possesses the same functional domains that lead to increased transduction efficiency in FN by colocalization of bound virus and cells, we hypothesized that Tat could enhance gene transfer by a similar mechanism.
METHODS: Single-cycle replication retro- or lentivirus carrying green fluorescent protein or cloramphenicol acetyltransferase as reporter genes were added to wells coated with Tat or Tat peptides. Wells were extensively washed to remove unbound virus and levels of transduction were detected by measuring reporter gene expression. Virus adsorption to immobilized Tat was measured using a p24 antigen capture assay.
RESULTS: Immobilized Tat efficiently binds retro- and lentiviral particles and mediates virus transmission at virus input doses that were otherwise unable to transduce susceptible cells. Virus adsorption to Tat is not mediated by envelope glycoprotein (Env) because immobilized Tat binds and retains vesicular stomatitis virus G (VSV-G) pseudotypes as well as envelope-free particles. HIV-1 Env or VSV-G are required for Tat-assisted transduction, which is abrogated by an antibody blocking the HIV-1 Env-CD4 interaction. Tat-assisted transduction is mediated by the cysteine-rich region of Tat, which is known to be essential for Tat transactivation activity. However, Tat transactivation is not required for Tat-assisted transduction, as indicated by the enhancement of transduction by transactivation-silent Tat mutants.
CONCLUSIONS: Immobilized Tat promotes virus transduction by a transactiva- tion-independent mechanism, which requires binding of virus to Tat. Recombinant Tat or Tat fragments provide a new method to increase efficiency of retro- and lentiviral based gene transfer and gene therapy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19653251     DOI: 10.1002/jgm.1381

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  7 in total

1.  Novel biopanning strategy to identify epitopes associated with vaccine protection.

Authors:  Barbara C Bachler; Michael Humbert; Brisa Palikuqi; Nagadenahalli B Siddappa; Samir K Lakhashe; Robert A Rasmussen; Ruth M Ruprecht
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

2.  Therapeutic immunization with HIV-1 Tat reduces immune activation and loss of regulatory T-cells and improves immune function in subjects on HAART.

Authors:  Barbara Ensoli; Stefania Bellino; Antonella Tripiciano; Olimpia Longo; Vittorio Francavilla; Simone Marcotullio; Aurelio Cafaro; Orietta Picconi; Giovanni Paniccia; Arianna Scoglio; Angela Arancio; Cristina Ariola; Maria J Ruiz Alvarez; Massimo Campagna; Donato Scaramuzzi; Cristina Iori; Roberto Esposito; Cristina Mussini; Florio Ghinelli; Laura Sighinolfi; Guido Palamara; Alessandra Latini; Gioacchino Angarano; Nicoletta Ladisa; Fabrizio Soscia; Vito S Mercurio; Adriano Lazzarin; Giuseppe Tambussi; Raffaele Visintini; Francesco Mazzotta; Massimo Di Pietro; Massimo Galli; Stefano Rusconi; Giampiero Carosi; Carlo Torti; Giovanni Di Perri; Stefano Bonora; Fabrizio Ensoli; Enrico Garaci
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

3.  HIV-1 Tat immunization restores immune homeostasis and attacks the HAART-resistant blood HIV DNA: results of a randomized phase II exploratory clinical trial.

Authors:  Fabrizio Ensoli; Aurelio Cafaro; Anna Casabianca; Antonella Tripiciano; Stefania Bellino; Olimpia Longo; Vittorio Francavilla; Orietta Picconi; Cecilia Sgadari; Sonia Moretti; Maria R Pavone Cossut; Angela Arancio; Chiara Orlandi; Leonardo Sernicola; Maria T Maggiorella; Giovanni Paniccia; Cristina Mussini; Adriano Lazzarin; Laura Sighinolfi; Guido Palamara; Andrea Gori; Gioacchino Angarano; Massimo Di Pietro; Massimo Galli; Vito S Mercurio; Francesco Castelli; Giovanni Di Perri; Paolo Monini; Mauro Magnani; Enrico Garaci; Barbara Ensoli
Journal:  Retrovirology       Date:  2015-04-29       Impact factor: 4.602

4.  Continued Decay of HIV Proviral DNA Upon Vaccination With HIV-1 Tat of Subjects on Long-Term ART: An 8-Year Follow-Up Study.

Authors:  Cecilia Sgadari; Paolo Monini; Antonella Tripiciano; Orietta Picconi; Anna Casabianca; Chiara Orlandi; Sonia Moretti; Vittorio Francavilla; Angela Arancio; Giovanni Paniccia; Massimo Campagna; Stefania Bellino; Marianna Meschiari; Silvia Nozza; Laura Sighinolfi; Alessandra Latini; Antonio Muscatello; Annalisa Saracino; Massimo Di Pietro; Massimo Galli; Aurelio Cafaro; Mauro Magnani; Fabrizio Ensoli; Barbara Ensoli
Journal:  Front Immunol       Date:  2019-02-13       Impact factor: 7.561

Review 5.  Anti-Tat Immunity in HIV-1 Infection: Effects of Naturally Occurring and Vaccine-Induced Antibodies Against Tat on the Course of the Disease.

Authors:  Aurelio Cafaro; Antonella Tripiciano; Orietta Picconi; Cecilia Sgadari; Sonia Moretti; Stefano Buttò; Paolo Monini; Barbara Ensoli
Journal:  Vaccines (Basel)       Date:  2019-08-26

6.  HIV-1 tat promotes integrin-mediated HIV transmission to dendritic cells by binding Env spikes and competes neutralization by anti-HIV antibodies.

Authors:  Paolo Monini; Aurelio Cafaro; Indresh K Srivastava; Sonia Moretti; Victoria A Sharma; Claudia Andreini; Chiara Chiozzini; Flavia Ferrantelli; Maria R Pavone Cossut; Antonella Tripiciano; Filomena Nappi; Olimpia Longo; Stefania Bellino; Orietta Picconi; Emanuele Fanales-Belasio; Alessandra Borsetti; Elena Toschi; Ilaria Schiavoni; Ilaria Bacigalupo; Elaine Kan; Leonardo Sernicola; Maria T Maggiorella; Katy Montin; Marco Porcu; Patrizia Leone; Pasqualina Leone; Barbara Collacchi; Clelia Palladino; Barbara Ridolfi; Mario Falchi; Iole Macchia; Jeffrey B Ulmer; Stefano Buttò; Cecilia Sgadari; Mauro Magnani; Maurizio P M Federico; Fausto Titti; Lucia Banci; Franco Dallocchio; Rino Rappuoli; Fabrizio Ensoli; Susan W Barnett; Enrico Garaci; Barbara Ensoli
Journal:  PLoS One       Date:  2012-11-13       Impact factor: 3.240

7.  The presence of anti-Tat antibodies in HIV-infected individuals is associated with containment of CD4+ T-cell decay and viral load, and with delay of disease progression: results of a 3-year cohort study.

Authors:  Stefania Bellino; Antonella Tripiciano; Orietta Picconi; Vittorio Francavilla; Olimpia Longo; Cecilia Sgadari; Giovanni Paniccia; Angela Arancio; Gioacchino Angarano; Nicoletta Ladisa; Adriano Lazzarin; Giuseppe Tambussi; Silvia Nozza; Carlo Torti; Emanuele Focà; Guido Palamara; Alessandra Latini; Laura Sighinolfi; Francesco Mazzotta; Massimo Di Pietro; Giovanni Di Perri; Stefano Bonora; Vito S Mercurio; Cristina Mussini; Andrea Gori; Massimo Galli; Paolo Monini; Aurelio Cafaro; Fabrizio Ensoli; Barbara Ensoli
Journal:  Retrovirology       Date:  2014-06-24       Impact factor: 4.602

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.